Chapter 496 Star Group

The second phase of the human clinical trial of cancer generic drugs is being held in a mighty manner, which is a one-month clinical trial.

The one-month clinical trial has only been carried out for two days, but the initial results can already be seen from the two-day clinical trial.

No matter what kind of cancer patients, the two-day drug has already played a certain role in their body, and some effects can be seen from it.

Patients with advanced cancer are the most sensitive group of people, because people in this period often not only have one disease, but also various complications.

It is precisely because they are the most sensitive people that their bodies get better, and they are also the people who can feel the changes the most.

Almost on the second day, they felt the changes in their bodies, which were positive changes, and the changes were extremely obvious.

When they conducted the test on the second day, some people posted their personal physical conditions through Weibo and Moments, and shared them with their family, relatives and friends.

"Thank you very much for Xingchen Pharmaceutical. They gave me hope. After taking their medicine, I feel much better. I look forward to seeing the brand new me in a month."

"After taking the medicine for only one day, I feel much better. Xingchen Pharma has given me hope for cancer treatment."

"This is a comparison of the data of taking the drug and not taking the drug. I will publish a data every day as a record, looking forward to it."

"In one day, I saw the hope of treating cancer. Even if it fails, I hope everyone will not blame Xingchen Pharmaceutical too much. This is a company that strives for the hope of cancer patients."

On this day, almost all people shared their feelings of doing the second phase of human clinical trials in Xingchen Pharmaceutical in their circle of friends.

More than 7,000 cancer patients from all over the country, after sharing their feelings.

A hot search about "Xingchen Pharmaceutical, a universal drug for cancer treatment" quickly entered the 24-hour hot search list.

The relatives and friends of these more than 7,000 terminal cancer patients basically know their status. Seeing them say that they have seen hope of survival in Xingchen Pharmaceutical, they can't help but cheer for it in their hearts.

Those who are more concerned about the efficacy of Xingchen Pharma's general cancer drug are those who are about to participate in the third phase of human clinical trials. Seeing that people in the second phase have improved after taking the drug, they seem to see their own hope.

Not only them, more cancer patients are paying attention to the news of Shangxingchen Pharmaceutical's general cancer drug.

"Xingchen Pharmaceutical 666 is really produced by Xingchen. It must be a high-quality product. Whether it is a technology product or a pharmaceutical product, it is a first-class existence. I seem to see the rise of Xingchen Beverage 'Strengthen'."

"It's really effective, isn't it fraudulent? Now there are many companies that deliberately use fake news to fool people."

"How can a subsidiary of Xingchen Technology be falsified, and the news of these people is not the information released by Xingchen Pharmaceutical itself, but the information released by the people who participated in the clinical trial. Many people can confirm that the information of these people is not fake. of."

"That's right, how could it be fake? I hope Xingchen Pharma will be more powerful now. After the second phase is completed, I will slap in the face of those who say they are fraudulent."

"Brothers above, you're not right, I'm wrong, don't slap me in the face, I hope it's true, because my own family has cancer, and I also hope that this medicine can really treat cancer, so I can I don't have to lose my relatives."

"Support Xingchen Pharmaceutical, as long as this drug can be successfully launched, I will definitely support it."

"+1 for support."

"Support +10086."

No matter how hot the Internet is about the general cancer drug produced by Xingchen Pharmaceutical, Xingchen Pharmaceutical has not made any response to the information on the Internet, and the second phase of human clinical trials are proceeding in an orderly manner.

Although Xingchen Pharmaceutical did not officially release any news, it did not prevent patients from revealing their condition.

Hou Yaolin has sufficient information about this drug, and the information released by patients is all information that has become better, which is also a disguised advertisement for Xingchen Pharmaceutical.

Since it became a hot topic, the topic of generic cancer drugs has not been in the top ten.

Of the 24-hour hot topics, topics related to stars account for half of them.

Netizens have been surprised by this for the past month.

Whether it is the company of Xingchen Technology, Xingchen Pharmaceutical, or Xingchen Beverage, the information given by each company is eye-catching, even if it is not directly named after Xingchen Group, it is related to Xingchen Group.

Yes, I read that right. With the permission of Liu Mingyu, with more and more subsidiaries, Liu Mingyu established Xingchen Group.

It can be said that the Xingchen Group has changed from an ordinary company to a group company at the fastest speed, breaking all kinds of records.

This is also impossible. As more and more companies are acquired, setting up a group company is the best choice.

With Zhao Qingsong and the other elites, he didn't need to do anything, and soon established a group company headed by Xingchen Technology.

At present, the subsidiaries are mainly divided into three, Xingchen Technology, Xingchen Pharmaceutical, and Xingchen Beverage.

The valuation of each company is very amazing, but the most amazing is the valuation of Xingchen Technology. Unfortunately, Xingchen Technology is not listed, and many venture capital companies can only evaluate based on current information.

This kind of assessment is inaccurate, because the information they can obtain is too little, but even so, the valuation of Xingchen Group has reached the trillion level in the venture capital industry.

Yes, you heard it right, it has reached the trillion level. Even the top investment companies have taken a fancy to the Xingchen Group with this level of financing, because they know that as long as they get on this line, they can make a profit without losing money.

The Xingchen Group has risen too fast, and before they can do a good job in the valuation, the Xingchen Group has released a product that surpasses the times, forcing them to re-evaluate.

Liu Mingyu rejected too many people's investment, and Liu Mingyu didn't want others to get involved in the company in his hands.

For the main leaders of some people's companies, he would rather increase the rewards for them and give them more money than give them his own shares.

With more shareholders, some information needs to be disclosed to those shareholders.

Liu Mingyu has too much information to hide, so it is the best choice to keep the company firmly in his own hands.

What's more, with the zombie conversion factory, it is a better choice to be able to make zombies that are loyal to themselves.

Not only Xingchen Pharmaceutical is operating in an orderly manner, Xingchen Technology and Xingchen Beverage are all operating in an orderly manner, and there are zombies headed by Zhao Qingsong who manage the company in an orderly manner.